Therefore, it is interesting to speculate that by blocking stimulation of the NF-κB pathway, NSAIDs modulate the tumour microenvironment to reduce the presence of inflammatory cells/cytokines, while stimulation of the pathway in a non-inflammatory environment mediates apoptosis of colorectal cancer cells. Here, NFKB1 is linked to colorectal cancer.